Effects of amiodarone, sematilide, and sotalol on QT dispersion

This publication has 19 references indexed in Scilit:

• Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
  Circulation, 1993
• Safety and efficacy of oral sotalol for sustained ventricular tachyarrhythmias refractory to other antiarrhythmic agents
  The American Journal of Cardiology, 1993
• Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE study)
  The American Journal of Cardiology, 1993
• Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
  Circulation, 1992
• Effect of amiodarone on mortality after myocardial infarction: A double-blind, placebo-controlled, pilot study
  Journal of the American College of Cardiology, 1992
• Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial, and M cells.
  Circulation Research, 1991
• QT dispersion: an indication of arrhythmia risk in patients with long QT intervals.
  Heart, 1990
• The historical development, cellular electrophysiology and pharmacology of amiodarone
  Progress in Cardiovascular Diseases, 1989
• Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation
  Journal of the American College of Cardiology, 1989
• Electrophysiological and Beta-Receptor Blocking Effects of MJ 1999 on Dog and Rabbit Cardiac Tissue
  Circulation Research, 1970